Axonics® to Participate in Upcoming Investor Conferences
08/27/2021 - 06:00 AM
IRVINE, Calif. --(BUSINESS WIRE)--
Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that senior management will present at the following virtual investor conferences:
Event: Wells Fargo Healthcare Conference
Date: Thursday, September 9, 2021
Time: 12:00 p.m. Eastern Time
Event: Morgan Stanley Healthcare Conference
Date: Monday, September 13, 2021
Time: 12:30 p.m. Eastern Time
Event: Baird Healthcare Conference
Date: Wednesday, September 15, 2021
Time: 1:25 p.m. Eastern Time
Interested parties may access a live and archived webcast of each fireside chat by visiting the Axonics investor relations website .
About Axonics
Based in Irvine, Calif. , Axonics is a global medical technology company that is developing and commercializing novel products for patients with bladder and bowel dysfunction. The company’s rechargeable sacral neuromodulation (SNM) system provides patients suffering from overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, Axonics’ best-in-class urethral bulking agent, Bulkamid® , provides women suffering from stress urinary incontinence (SUI) with safe and durable symptom relief.
Overactive bladder affects an estimated 87 million adults in the U.S. and Europe , with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 20 million women in the U.S. alone. Axonics’ clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com .
View source version on businesswire.com : https://www.businesswire.com/news/home/20210827005029/en/
Axonics contact :
Neil Bhalodkar
Investor Relations
949-336-5293
ir@axonics.com
Source: Axonics, Inc.
AXNX Rankings
#3982 Ranked by Stock Gains
AXNX Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Irvine
About AXNX
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.